Izabela Broniarek

Dr. Izabela Broniarek

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JHJolanta Hybiak
Jolanta Hybiak
IBIzabela Broniarek
Izabela Broniarek
GKGerard Kiryczyński
Gerard Kiryczyński
LLLaura.D. Los
Laura.D. Los
Jakub RosikJakub Rosik
Jakub Rosik
EUElżbieta Urasińska
Elżbieta Urasińska

Verified
Journal Article
Open access
PDF file
IBIzabela Broniarek
Izabela Broniarek
KDKarolina Dominiak
Karolina Dominiak
LGLukasz Galganski
Lukasz Galganski
WJWieslawa Jarmuszkiewicz
Wieslawa Jarmuszkiewicz
Endothelial mitochondrial dysfunction is considered to be the main cause of cardiovascular disease. The aim of this research was to elucidate the effects of cholesterol-lowering statins on the aerobic metabolism of endothelial cells at the cellular and mitochondrial levels. In human umbilical vein endothelial cells (EA.hy926), six days of exposure to 100 nM atorvastatin (ATOR) induced a general decrease in mitochondrial respiration. No changes in mitochondrial biogenesis, cell viability, or ATP levels were observed, whereas a decrease in Coenzyme Q10 (Q10) content was accompanied by an increase in intracellular reactive oxygen species (ROS) production, although mitochondrial ROS production remained unchanged. The changes caused by 100 nM pravastatin were smaller than those caused by ATOR. The ATOR-induced changes at the respiratory chain level promoted increased mitochondrial ROS production. In addition to the reduced level of mitochondrial Q10, the activity of Complex III was decreased, and the amount of Complex III in a supercomplex with Complex IV was diminished. These changes may cause the observed decrease in mitochondrial membrane potential and an increase in Q10 reduction level as a consequence, leading to elevated mitochondrial ROS formation. The above observations highlight the role of endothelial mitochondria in response to potential metabolic adaptations related to the chronic exposure of endothelial cells to statins.

12 December 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JZJerzy A Zoladz
Jerzy A Zoladz
AKAgnieszka Koziel
Agnieszka Koziel
IBIzabela Broniarek
Izabela Broniarek
AWAndrzej Marek Woyda-Ploszczyca
Andrzej Marek Woyda-Ploszczyca
KOKarolina Ogrodna
Karolina Ogrodna
WJWieslawa Jarmuszkiewicz
Wieslawa Jarmuszkiewicz
We studied the effects of various assay temperatures, representing hypothermia (25°C), normothermia (35°C), and hyperthermia (42°C), on the oxidation of lipid-derived fuels in rat skeletal muscle mitochondria of untrained and endurance-trained rats. Adult 4-month-old male Wistar rats were assigned to a training group (rats trained on a treadmill for 8 weeks) or a sedentary control group. In skeletal muscle mitochondria of both control and trained rats, an increase in the assay temperature from 25°C to 42°C was accompanied by a consistent increase in the oxidation of palmitoylcarnitine and glycerol-3-phosphate. Moreover, endurance training increased mitochondrial capacity to oxidize the lipid-derived fuels at all studied temperatures. The endurance training-induced increase in mitochondrial capacity to oxidize fatty acids was accompanied by an enhancement of mitochondrial biogenesis, as shown by the elevated expression levels of Nrf2, PGC1α, and mitochondrial marker and by the elevated expression levels of mitochondrial proteins involved in fatty acid metabolism, such as fatty acid transporter CD36, carnitine palmitoyltransferase 1A (CPT1A), and acyl-CoA dehydrogenase (ACADS). We conclude that hyperthermia enhances but hypothermia attenuates the rate of the oxidation of fatty acids and glycerol-3-phosphate in rat skeletal muscle mitochondria isolated from both untrained and trained rats. Moreover, our results indicate that endurance training up-regulates mitochondrial biogenesis markers, lipid-sustained oxidative capacity, and CD36 and CPT1A proteins involved in fatty acid transport, possibly via PGC1α and Nrf2 signaling pathways.

14 July 2016 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Open access
PDF file
IBIzabela Broniarek
Izabela Broniarek
AKAgnieszka Koziel
Agnieszka Koziel
WJWieslawa Jarmuszkiewicz
Wieslawa Jarmuszkiewicz
A chronic elevation of circulating free fatty acids (FFAs) is associated with diseases like obesity or diabetes and can lead to lipotoxicity. The goals of this study were to assess the influence of chronic exposure to high palmitic acid (PAL) levels on mitochondrial respiratory functions in endothelial cells and isolated mitochondria. Human umbilical vein endothelial cells (EA.hy926 line) were grown for 6 days in a medium containing either 100 or 150 μM PAL. Growth at high PAL concentrations induced a considerable increase in fatty acid-supplied respiration and a reduction of mitochondrial respiration during carbohydrate and glutamine oxidation. High PAL levels elevated intracellular and mitochondrial superoxide generation; increased inflammation marker, acyl-coenzyme A (CoA) dehydrogenase, uncoupling protein 2 (UCP2), and superoxide dismutase 2 expression; and decreased hexokinase I and pyruvate dehydrogenase expression. No change in aerobic respiration capacity was observed, while fermentation was decreased. In mitochondria isolated from high PAL-treated cells, an increase in the oxidation of palmitoylcarnitine, a decrease in the oxidation of pyruvate, and an increase in UCP2 activity were observed. Our results demonstrate that exposure to high PAL levels induces a shift in endothelial aerobic metabolism toward the oxidation of fatty acids. Increased levels of PAL caused impairment and uncoupling of the mitochondrial oxidative phosphorylation system. Our data indicate that FFAs significantly affect endothelial oxidative metabolism, reactive oxygen species (ROS) formation, and cell viability and, thus, might contribute to endothelial and vascular dysfunction.

1 September 2020 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JHJolanta Hybiak
Jolanta Hybiak
KJKornelia Jankowska
Kornelia Jankowska
FMFilip Machaj
Filip Machaj
Jakub RosikJakub Rosik
Jakub Rosik
IBIzabela Broniarek
Izabela Broniarek
EUElżbieta Urasińska
Elżbieta Urasińska

1 January 2018 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
IBIzabela Broniarek
Izabela Broniarek
WJWieslawa Jarmuszkiewicz
Wieslawa Jarmuszkiewicz